CION Ameerpet
Stage 1 means the cancer is confined to the ovary or ovaries — or to the fallopian tube — with nothing found beyond it. It carries the best outlook of any stage, and for some women treatment ends with the surgery itself. Two questions decide what happens next: whether your staging was complete, and which substage you were given.
Stage describes how far the cancer has travelled, not how aggressive it is — grade describes that, and the two are separate. Stage 1 ovarian cancer means the disease is confined to one or both ovaries, or to the fallopian tube. No deposits in the abdomen, no involved lymph nodes, nothing in the chest.
Fewer women are diagnosed at this stage than anyone would like, and the reason is blunt: there is no effective screening test for ovarian cancer, for anyone, including women who carry a BRCA variant. Most stage 1 cancers are found by accident — a cyst removed for a different reason, a scan done for something else, or a single symptom investigated early. If yours was found that way, that is luck working in your favour.
Two things now decide what happens next, and neither is obvious from the words stage 1 alone. The first is whether the operation you had was a complete staging procedure. The second is your substage — IA, IB or IC — because IC in particular changes what is advised. Both are covered below. For how the whole system fits together, see FIGO staging for ovarian cancer explained.
Nothing found beyond it — no deposits in the abdomen, no involved nodes, nothing in the chest.
Two separate things. A stage 1 cancer can still be high grade, and that changes the plan.
There is no screening test that works. Most early disease turns up while looking for something else.
Stage 1C is not one thing — it is three, and the difference matters. Under the FIGO 2014 staging system, IC1 means the tumour capsule burst during the operation itself, IC2 means it had already ruptured before surgery or tumour was growing on the ovary's surface, and IC3 means cancer cells were found in ascites or in washings taken from the abdomen. All three read simply as 1C on a pathology report, yet they describe quite different situations, and the reason for yours is recorded in the operation note rather than the pathology report. If your report says 1C, it is worth asking which one. Source: FIGO 2014 staging classification for cancer of the ovary, fallopian tube and peritoneum.
Stage 1 is subdivided by whether anything has breached the ovary. Your histopathology report will name one of these.
| Substage | What it describes | Why it matters |
|---|---|---|
| IA | One ovary or one fallopian tube. Capsule intact, no tumour on the surface, washings clear. | The earliest presentation. Where low-grade IA disease has been completely staged, chemotherapy is not always advised. |
| IB | The same picture, but both ovaries or both tubes are involved. | Uncommon. Managed much like IA, with the same questions about grade and completeness of staging. |
| IC1 | The tumour capsule burst during the operation itself — surgical spill. | Cells may have been released into the abdomen, so adjuvant chemotherapy is usually recommended. |
| IC2 | The capsule had already ruptured before surgery, or tumour was growing on the ovary's surface. | Suggests the disease had breached the ovary before anyone operated. |
| IC3 | Cancer cells found in ascites, or in peritoneal washings taken at surgery. | Cells were already loose in the abdominal cavity, even though no deposits were visible. |
*The pathology report names the substage. The reason behind a 1C sits in the operation note — ask for both, and keep copies.
Some are made for you by the pathology. Others are genuine choices, and are easier to influence if you know they exist.
This is the most important question at stage 1, and it is frequently not asked. Calling a cancer stage 1 means nothing was found elsewhere — but that only holds if someone looked. A complete staging operation means taking peritoneal washings, removing the affected ovary and tube, removing the omentum, biopsying the peritoneal surfaces, and assessing the pelvic and para-aortic lymph nodes.
Where staging is incomplete, some apparently stage 1 cancers turn out to be more advanced once the missing tissue is examined — which is precisely why the operation is done that way. If your surgery was a straightforward cyst removal and the cancer was an unexpected finding, ask whether you were completely staged and what should happen now. This surgery is coordinated with specialist gynaecologic-oncology partner centres and may be billed there.
Not everyone at this stage does, and that surprises people. The decision turns on three things: your substage, the grade of the cancer, and its subtype. Completely staged, low-grade IA disease is often managed with careful follow-up alone, because chemotherapy would add side effects without adding much. Stage IC disease, high-grade disease and clear cell tumours are generally offered adjuvant chemotherapy after surgery.
Where it is advised, chemotherapy is platinum-based and given over a small number of cycles — considerably fewer than at advanced stages. It is delivered in-house at CION across 35+ centres in Telangana and Andhra Pradesh. If chemotherapy has been recommended, ask what it adds on top of the surgery. If it has not been, ask why not. See ovarian cancer treatment in Hyderabad.
Often, yes — and this is one of the few places in ovarian cancer where the answer is genuinely encouraging. In selected early disease, particularly stage IA in a younger woman and particularly with germ cell tumours, it is possible to remove only the affected ovary and tube while leaving the uterus and the other ovary in place. Complete staging is still carried out.
It is not right for everyone: substage, grade and subtype all bear on it. Raise it before surgery if you possibly can, because it is far harder to undo afterwards than to plan for in advance. See fertility-sparing surgery for ovarian cancer. Like all ovarian surgery at CION, it is coordinated with specialist gynaecologic-oncology partner centres and may be billed there.
An early stage does not make an inherited cause less likely. Testing is recommended for ovarian cancer regardless of stage, because the result affects your relatives as much as it affects you — a BRCA result in you means sisters, daughters, mother and brothers can be offered testing, and if positive, real risk-reducing options.
Genetic counselling, BRCA testing and HRD testing are delivered in-house at CION. The counselling before the test matters as much as the result: it is what makes the answer usable rather than frightening. If nobody has raised testing with you, ask.
After treatment you will be seen regularly — examination, symptom review, and usually CA-125 if it was raised at diagnosis. Follow-up exists to pick up a recurrence early and to manage the after-effects of treatment, including early menopause where both ovaries were removed.
Be clear about what surveillance is not. It is not screening, and a normal CA-125 is not a guarantee. The most useful thing you can do between appointments is report a new symptom that persists, rather than waiting for the next scheduled visit. Menopause and nutrition support are part of this, not extras.
Short questions with specific answers. Several are rarely covered unless you raise them.
Washings, omentum, peritoneal biopsies and lymph node assessment — not only removal of the ovary.
And if 1C, whether it was IC1, IC2 or IC3. The reason sits in the operation note.
Stage says how far. Grade and subtype say how it behaves, and they drive the chemotherapy decision.
A yes and a no are both reasonable at this stage. Ask what the answer is based on.
Recommended at every stage. The result matters for your relatives as much as for you.
Best raised before surgery. Fertility-sparing surgery is possible in selected early disease.
If your cancer was found unexpectedly during surgery for a cyst, ask specifically whether a second staging procedure is being considered, and what it would change.
Most women at this stage are treated with the intent of cure. The useful work now is checking that the staging was complete, and that the plan matches your substage, grade and subtype.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them - together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
No referral needed and no cost for the first consultation. Chemotherapy, genetic counselling and BRCA testing are delivered in-house at CION across 35+ centres.
A large share of stage 1 ovarian cancers are diagnosed after the fact. A cyst is removed for pain, or for its size, or because it looked complex on a scan — and the pathology comes back showing cancer nobody was expecting. If that is your situation, you are not an unusual case.
The difficulty is that an operation planned as a cyst removal is not a staging operation. Washings may not have been taken, the omentum is still in place, the peritoneal surfaces were not biopsied, and the lymph nodes were not assessed. Without those, the label stage 1 is provisional: it describes what was seen, not what was searched for.
What follows is a real decision rather than an automatic one. Sometimes a second procedure to complete the staging is advised, because the result changes whether chemotherapy is needed. Sometimes, where the grade and subtype are low risk, the balance falls the other way. Occasionally chemotherapy is given to cover the uncertainty instead. Ask which applies to you and what it rests on — it is a reasonable thing to take for a free second opinion, because the answer is not the same for everyone.
Stage 1 after an unstaged operation describes what was seen, not what was looked for.
A second procedure to complete the staging, where the result would change the treatment plan.
Low-risk and high-risk grade and subtype pull the same decision in opposite directions.
Everyone diagnosed here looks up stage 1 ovarian cancer survival, and the figures found online are the most encouraging in the whole disease. They are also the ones most easily misread, in three specific ways.
They are historical, describing women treated years ago under different surgical and testing standards. They are averages across everything — IA and IC together, low grade and high grade together, every subtype together — when a completely staged low-grade IA and a high-grade IC are not the same illness at all. And crucially at this stage, they mix completely staged women with incompletely staged ones, some of whom in fact had more advanced disease that was never found. A figure built that way cannot describe your own situation.
CION publishes its own one-year survival alongside the national figure so the comparison is at least visible: 81.0% of CION ovarian cancer patients are alive at one year, against a national figure of 73.7%. That is across all stages rather than stage-specific, and it is a one-year figure rather than a cure rate. What shapes your own outlook is your substage, your grade and subtype, and whether the staging was complete — a conversation for your treating oncologist, who can speak to your actual case.
CION ovarian cancer patients alive at one year from diagnosis. *One-year survival, CION treated population, all stages.
The comparable national figure. *One-year survival; national registry data, all stages.
Substages with different risk profiles collapsed into one number, alongside every grade and subtype.
Some of whom had disease beyond the ovary that nobody ever looked for.
*One-year survival rates across all stages. CION figures reflect CION's treated patient population; national figures are drawn from published Indian cancer registry data. Survival statistics describe groups rather than individuals — discuss your own prognosis with your treating oncologist.
Stage 1 brings a particular kind of unease. The news is comparatively good, treatment may be short or already finished, and yet nobody has quite explained what the label rests on. Women commonly leave knowing the word early was used, and very little else.
Your first consultation at CION is free and runs to about 45 minutes. Bring your histopathology report, your operation note and your imaging — the operation note especially, because at this stage it holds answers the pathology report does not. Most of the useful work is establishing whether the staging was complete, what your substage and grade mean in practice, and whether chemotherapy is adding anything.
We should be clear about the division. Chemotherapy, genetic counselling, BRCA and HRD testing, nutrition support and long-term follow-up are delivered in-house at CION across 35+ centres in Telangana and Andhra Pradesh. Staging surgery, restaging and fertility-sparing surgery are coordinated with specialist gynaecologic-oncology partner centres and may be billed there — arranged that way because specialist surgery genuinely changes outcomes in this disease. Every case goes to a tumour board. If you want the wider picture first, start with the complete ovarian cancer guide.
Free and unhurried. Long enough to go through the operation note line by line.
Medical oncology, pathology and imaging review the plan together before it is settled.
Staging and fertility-sparing surgery at specialist partner centres, and may be billed there. Stated upfront.
CION patients on the supported nutrition pathway, which affects how well treatment is tolerated.
It means the cancer is confined to one or both ovaries, or to the fallopian tube, with nothing found beyond it — no deposits in the abdomen, no involved lymph nodes and nothing in the chest. Stage describes how far the disease has travelled, not how aggressive it is; that is what grade describes, and the two are separate, so a stage 1 cancer can still be high grade. Stage 1 is the earliest stage there is and carries the best outlook of any. Two things decide what happens next: whether the operation you had was a complete staging procedure, and which substage you were given — IA, IB or IC.
It is treated with the intent of cure, and most women at this stage do very well. For some — completely staged, low-grade IA disease — treatment ends with the surgery itself and no chemotherapy is needed. The honest qualification is that stage 1 is not one situation. A fully staged low-grade IA cancer and a high-grade IC cancer are different illnesses, and the risk of recurrence differs accordingly. What matters most is whether the staging was genuinely complete, because a cancer labelled stage 1 without washings, omentum and node assessment may be a more advanced cancer that was never fully searched for. Your oncologist can speak to your own combination of substage, grade and subtype.
IA means the cancer is in one ovary or one fallopian tube, with the capsule intact, no tumour on the surface and clear washings. IB is the same picture but with both ovaries or both tubes involved, and is uncommon. IC means the cancer is still confined to the ovaries or tubes, but something has breached that boundary — and it is subdivided three ways. IC1 means the capsule burst during the operation itself. IC2 means it had already ruptured before surgery, or tumour was growing on the ovary's surface. IC3 means cancer cells were found in ascites or in peritoneal washings. All three appear simply as 1C on a report, so if yours says 1C, ask which one and check the operation note.
Not necessarily, and that surprises people. The decision rests on your substage, the grade of the cancer and its subtype. Completely staged, low-grade IA disease is often managed with careful follow-up alone, because chemotherapy would add side effects without adding much. Stage IC disease, high-grade disease and clear cell tumours are generally offered adjuvant chemotherapy after surgery. Where it is advised, it is platinum-based and given over a small number of cycles — considerably fewer than at advanced stages — and it is delivered in-house at CION across 35+ centres. If chemotherapy has been recommended, ask what it adds on top of the surgery. If it has not been, ask why not. Both are fair questions with clear answers.
Often, yes. In selected early disease — particularly stage IA in a younger woman, and particularly with germ cell tumours — it is possible to remove only the affected ovary and fallopian tube while leaving the uterus and the other ovary in place. Complete staging is still carried out. It is not right for everyone: substage, grade and subtype all bear on the decision, and some situations call for removing both ovaries. Raise it before surgery if you possibly can, because it is far harder to undo afterwards than to plan for in advance. At CION this surgery is coordinated with specialist gynaecologic-oncology partner centres and may be billed there, and fertility preservation is discussed alongside it.
This is common. Many stage 1 ovarian cancers are found after a cyst was removed for pain or for its size, when nobody was expecting cancer — and an operation planned as a cyst removal is not a staging operation. Washings may not have been taken, the omentum is still in place, the peritoneal surfaces were not biopsied and the lymph nodes were not assessed. Without those, the label stage 1 describes what was seen rather than what was searched for. Sometimes a second procedure to complete the staging is advised, because the result changes whether chemotherapy is needed. Sometimes, with low-risk histology, the balance falls the other way, and occasionally chemotherapy is given to cover the uncertainty. Ask which applies to you and why.
The first consultation is free and runs to about 45 minutes — bring your histopathology report, your operation note and your imaging. Chemotherapy is delivered in-house at CION across more than 35 centres in Telangana and Andhra Pradesh, as are genetic counselling, BRCA and HRD testing, nutrition support and long-term follow-up, where patients on the supported nutrition pathway experience 67% less weight loss during treatment. Staging surgery, restaging and fertility-sparing surgery are coordinated with specialist gynaecologic-oncology partner centres and may be billed there — arranged that way because specialist surgery genuinely changes outcomes in ovarian cancer. Every case is reviewed by a tumour board before a plan is settled.